| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1000005717 |
| P356 | DOI | 10.1007/S100249900011 |
| P698 | PubMed publication ID | 10463276 |
| P2093 | author name string | Kaler SG | |
| P433 | issue | 1 | |
| P921 | main subject | Menkes disease | Q639203 |
| occipital horn syndrome | Q3508729 | ||
| P304 | page(s) | 85-98 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Pediatric and Developmental Pathology | Q15758754 |
| P1476 | title | Metabolic and molecular bases of Menkes disease and occipital horn syndrome | |
| P478 | volume | 1 |
| Q79209622 | A comparison of the mutation spectra of Menkes disease and Wilson disease |
| Q28367963 | A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease |
| Q28302938 | ATP7A-related copper transport diseases-emerging concepts and future trends |
| Q81213904 | Acquired hypocupremia after gastric surgery |
| Q57405617 | Activation of ADP-ribosylation factor regulates biogenesis of the ATP7A-containing trans-Golgi network compartment and its Cu-induced trafficking |
| Q37983830 | Advances in the understanding of mammalian copper transporters |
| Q36597945 | Cell biology of membrane trafficking in human disease |
| Q41626358 | Characterizing the molecular phenotype of an Atp7a(T985I) conditional knock in mouse model for X-linked distal hereditary motor neuropathy (dHMNX). |
| Q92620527 | Classification and differential diagnosis of Wilson's disease |
| Q21128629 | Copper Deficiency Myelopathy (Human Swayback) |
| Q34622201 | Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships |
| Q37622792 | Copper in the brain and Alzheimer's disease |
| Q37166075 | Copper transport into the secretory pathway is regulated by oxygen in macrophages |
| Q38942904 | Copper transporters and chaperones: Their function on angiogenesis and cellular signalling |
| Q34061892 | Decreased erythrocyte CCS content is a biomarker of copper overload in rats. |
| Q92129362 | Defining the Clinical, Molecular and Ultrastructural Characteristics in Occipital Horn Syndrome: Two New Cases and Review of the Literature |
| Q99205405 | Detection of copper(II) in water by methylene blue derivatives |
| Q89927769 | Disorders of metal metabolism |
| Q21093171 | Dopamine beta-hydroxylase deficiency |
| Q40485488 | Epilepsy in Menkes disease: analysis of clinical stages. |
| Q37785978 | Genetics of Early Onset Cognitive Impairment |
| Q34436497 | Hair and systemic disease |
| Q81892365 | Identification and analysis of 21 novel disease-causing amino acid substitutions in the conserved part of ATP7A |
| Q41506806 | Impact of copper oxide nanomaterials on differentiated and undifferentiated Caco-2 intestinal epithelial cells; assessment of cytotoxicity, barrier integrity, cytokine production and nanomaterial penetration |
| Q42021732 | Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells |
| Q36275015 | Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. |
| Q36499173 | In vivo correction of a Menkes disease model using antisense oligonucleotides |
| Q34429101 | Inborn errors of copper metabolism |
| Q36571717 | Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain |
| Q39735458 | Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. |
| Q60111586 | Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease |
| Q39955033 | Localization of the Wilson disease protein in murine intestine. |
| Q26738363 | Menkes disease: what a multidisciplinary approach can do |
| Q37580771 | Mental retardation and inborn errors of metabolism. |
| Q24647056 | Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes |
| Q26770905 | Mottled Mice and Non-Mammalian Models of Menkes Disease |
| Q36928296 | Mutation in the ATP7A gene may not be responsible for hypocupraemia in copper deficiency myelopathy |
| Q42740783 | Occipital horn syndrome in a woman: skeletal radiological findings |
| Q44199178 | Pamidronate treatment improves bone mineral density in children with Menkes disease |
| Q79075108 | Rare Urological Abnormalities in 2 Cases of Menkes’ Syndrome |
| Q28508433 | Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity |
| Q37112824 | Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis |
| Q38575035 | Targeting copper in cancer therapy: 'Copper That Cancer'. |
| Q33675590 | The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin |
| Q46024813 | The use of categorical regression in modeling copper exposure-response relationships. |
| Q34989947 | Understanding the mechanism and function of copper P-type ATPases |
Search more.